4//SEC Filing
Hirsch David 4
Accession 0001209191-21-041511
CIK 0001661460other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:03 PM ET
Size
5.4 KB
Accession
0001209191-21-041511
Insider Transaction Report
Form 4
Hirsch David
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+20,000→ 20,000 totalExercise: $8.98Exp: 2031-06-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option will vest and become fully exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the next annual meeting of the stockholders of the Issuer.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001619884
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:03 PM ET
- Size
- 5.4 KB